Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
|
|
Perspectives
Submitted on June 6, 2002 D-Day for BRCA2
1 The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London SW3 6JB UK. * To whom correspondence should be addressed. E-mail: ewitt{at}icr.ac.uk. Individuals with certain mutations in the gene BRCA2 are at very high risk for developing breast cancer, because a DNA repair pathway cannot properly repair ongoing wear and tear to the DNA. Now Howlett et al. show that other mutations in this same gene BRCA2 are one cause of another disease, Fanconi Anemia, also thought to be a result of defective DNA repair. In their Perspective, Witt and Ashworth explain how this unexpected result pinpoints BRCA2 as a central control point in the DNA repair mechanism of cells, which maintains the stability of the genome.
The editors suggest the following Related Resources on Science sites:In Science Magazine
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
|
Science. ISSN 0036-8075 (print), 1095-9203 (online)